HELICOBACTER INFECTION
Clinical trials for HELICOBACTER INFECTION explained in plain language.
Never miss a new study
Get alerted when new HELICOBACTER INFECTION trials appear
Sign up with your email to follow new studies for HELICOBACTER INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Battle of the bacteria: which h. pylori treatment wins?
Disease control Recruiting nowThis study compares two antibiotic treatments for H. pylori, a stomach infection. 600 adults will get either a 10-day standard treatment or a 7-day treatment tailored to their bacteria's drug resistance. The goal is to see which approach eradicates the infection more effectively.
Matched conditions: HELICOBACTER INFECTION
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy could beat stubborn stomach bug
Disease control Recruiting nowThis study tests a newer acid-blocking drug (vonoprazan) against a standard one, each combined with vitamin D or probiotics, to treat H. pylori infection. About 66 adults with confirmed H. pylori will receive one of three treatments for two weeks. The goal is to see which combina…
Matched conditions: HELICOBACTER INFECTION
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Stomach bug subtypes may raise cancer risk – study to track 3,000 people
Knowledge-focused Recruiting nowThis study follows 3,000 adults aged 40 and older who carry Helicobacter pylori, a common stomach bug. Researchers want to see if people with certain high-risk subtypes of the bacteria develop stomach cancer more often than those with other subtypes or no infection. Participants …
Matched conditions: HELICOBACTER INFECTION
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC